TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 343 filers reported holding TANDEM DIABETES CARE INC in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,901,000 | -73.1% | 133,481 | -47.2% | 0.01% | -66.7% |
| Q1 2022 | $29,407,000 | -2.4% | 252,873 | +26.4% | 0.03% | +3.4% |
| Q4 2021 | $30,115,000 | +931.7% | 200,075 | +718.2% | 0.03% | +866.7% |
| Q3 2021 | $2,919,000 | +137.1% | 24,452 | +75.3% | 0.00% | +200.0% |
| Q1 2021 | $1,231,000 | -94.3% | 13,950 | -93.8% | 0.00% | -96.4% |
| Q4 2020 | $21,462,000 | -35.3% | 224,315 | -23.2% | 0.03% | -47.2% |
| Q3 2020 | $33,150,000 | +482.0% | 292,071 | +407.2% | 0.05% | +430.0% |
| Q2 2020 | $5,696,000 | +89.6% | 57,581 | +23.4% | 0.01% | +42.9% |
| Q1 2020 | $3,004,000 | +78.8% | 46,679 | +65.7% | 0.01% | +133.3% |
| Q4 2019 | $1,680,000 | -45.6% | 28,179 | -46.2% | 0.00% | -50.0% |
| Q3 2019 | $3,091,000 | +8.8% | 52,412 | +19.0% | 0.01% | +20.0% |
| Q2 2019 | $2,842,000 | -32.7% | 44,050 | -33.7% | 0.01% | -37.5% |
| Q1 2019 | $4,220,000 | +39.0% | 66,457 | -16.9% | 0.01% | +14.3% |
| Q4 2018 | $3,037,000 | – | 79,974 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |